Oral Leukoplakia: Diagnosis, Malignant Potential, and Management

Oral leukoplakia is the most common oral potentially malignant disorder, presenting as a white plaque that cannot be scraped off and cannot be attributed to any other definable disease. Because a proportion of these lesions undergo malignant transformation to squamous cell carcino...

Oral leukoplakia is the most common oral potentially malignant disorder, presenting as a white plaque that cannot be scraped off and cannot be attributed to any other definable disease. Because a proportion of these lesions undergo malignant transformation to squamous cell carcinoma, early recognition, accurate risk assessment, and appropriate management are critical to reducing the burden of oral cancer.

What Is Oral Leukoplakia?

Oral leukoplakia is defined by the World Health Organization as a white plaque of questionable risk that cannot be characterized as any other definable lesion. The diagnosis is one of exclusion, made only after other causes of white lesions, such as lichen planus, candidiasis, frictional keratosis, and leukoedema, have been ruled out.

The condition is strongly associated with tobacco use, and it is more common in men and in older adults. The prevalence of oral leukoplakia worldwide is estimated at 1 to 4 percent of the population, making it a common finding in clinical practice.

Clinical Features

Oral leukoplakia can appear in several clinical forms, and the appearance carries prognostic significance.

Homogeneous Leukoplakia

The homogeneous form is a uniformly white, flat, and thin lesion with a smooth or slightly wrinkled surface. It is the most common form and carries the lowest risk of malignant transformation.

Non-Homogeneous Leukoplakia

The non-homogeneous form includes lesions with a mixed red and white appearance, such as erythroleukoplakia, nodular lesions, and verrucous lesions. These forms carry a significantly higher risk of malignant transformation than the homogeneous form. The presence of a red component, in particular, is a strong indicator of increased risk.

Malignant Transformation

The malignant transformation rate of oral leukoplakia is a subject of ongoing study. A landmark systematic review by Warnakulasuriya and Ariyawardana (2016) reported a global malignant transformation rate of approximately 3.5 percent, with higher rates in studies with longer follow-up. The transformation rate varies widely, from under 1 percent to over 17 percent, depending on the population and the duration of follow-up.

Several factors increase the risk of malignant transformation:

- Non-homogeneous clinical appearance

- Female gender

- Lesions on the tongue, floor of the mouth, or soft palate

- Lesions larger than 200 mm²

- The presence of epithelial dysplasia

- Continued tobacco and alcohol use

The floor of the mouth and the lateral border of the tongue are the highest-risk sites, and lesions in these locations warrant particularly close attention.

The Role of Epithelial Dysplasia

Epithelial dysplasia is the most important histopathological predictor of malignant transformation. Dysplasia is graded as mild, moderate, or severe based on the degree of architectural and cytological atypia. The risk of malignant transformation increases with the grade of dysplasia, with severe dysplasia and carcinoma in situ carrying the highest risk.

However, the absence of dysplasia does not guarantee a benign course. A proportion of leukoplakias that transform to carcinoma show no dysplasia in the initial biopsy, underscoring the need for long-term surveillance of all lesions.

Diagnosis

Clinical Examination

The diagnosis begins with a careful clinical examination. The lesion is inspected and palpated, and its size, site, and clinical appearance are documented. The patient's history of tobacco and alcohol use is recorded, and other potential causes of white lesions are considered.

Biopsy

Biopsy is essential for the definitive diagnosis of oral leukoplakia and for the assessment of dysplasia. An incisional biopsy is performed on the most suspicious area of the lesion, which is often the most erythematous or nodular region. In lesions with multiple suspicious areas, multiple biopsies may be required.

Adjunctive Diagnostic Aids

Several adjunctive techniques can assist in the assessment of oral leukoplakia. Vital staining with toluidine blue can highlight areas of increased cellular activity, and autofluorescence imaging can identify regions of altered tissue metabolism. While these tools can help guide biopsy site selection, they do not replace histopathological diagnosis.

Management

The management of oral leukoplakia is individualized based on the risk of malignant transformation.

Low-Risk Lesions

Small, homogeneous lesions without dysplasia may be managed conservatively. The patient is advised to eliminate risk factors, particularly tobacco and alcohol use, and the lesion is reviewed at regular intervals. Some lesions regress or resolve completely after cessation of the habit.

High-Risk Lesions

Lesions with dysplasia, non-homogeneous appearance, or high-risk sites are generally treated by surgical excision. Complete excision with clear margins is the goal, and the specimen is submitted for histopathological examination. Laser excision and cryotherapy are alternative modalities, but surgical excision with scalpel remains the standard for obtaining a reliable specimen.

The Challenge of Recurrence

Even after complete excision, oral leukoplakia has a significant recurrence rate, reported at 10 to 35 percent in different series. Recurrence may occur at the site of excision or at a new site, reflecting the field change that affects the entire oral mucosa in susceptible patients. This field cancerization concept explains why patients with one oral potentially malignant disorder are at risk of developing lesions elsewhere.

Long-Term Surveillance

All patients with oral leukoplakia, regardless of treatment, require long-term surveillance. The recommended follow-up interval is typically every three to six months, with more frequent review for high-risk lesions. At each visit, the entire oral mucosa is examined, and any new or recurrent lesion is biopsied.

Patient education is a cornerstone of management. Patients must understand the importance of tobacco and alcohol cessation, the signs of malignant change, and the need for lifelong follow-up.

Bottom Line

Oral leukoplakia is a common oral potentially malignant disorder with a malignant transformation rate of approximately 3.5 percent. The risk is highest in non-homogeneous lesions, lesions with dysplasia, and lesions on the tongue and floor of the mouth. Diagnosis requires biopsy, and management ranges from conservative surveillance for low-risk lesions to surgical excision for high-risk lesions. Long-term follow-up is essential for all patients, as recurrence and malignant transformation can occur years after initial treatment.